Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447629 · ClinicalTrials.gov registry record · Phase 1
Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart
A Phase 1 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00447629 is a Phase 1 study that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer.
The verdict
NCT00447629, a Phase 1 study, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
A study evaluating the safety of a high and low dose of PPM-204 on the electrical pathways of the heart.
Interventions
- DRUG PPM-204
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-01 |
| Est. Completion | 2007-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00447629
The ClinicalTrials.gov registry entry for NCT00447629 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PPM-204 is the first listed.
NCT00447629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00447629 about?
NCT00447629 is a clinical study titled "Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart". A study evaluating the safety of a high and low dose of PPM-204 on the electrical pathways of the heart.
What is the current status of trial NCT00447629?
This trial is currently completed. It is a Phase 1 study. The study started on 2007-01. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00447629?
The interventions under investigation include: PPM-204 (DRUG).
Who is sponsoring clinical trial NCT00447629?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.